COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL

Geert R. D'Haens  1     Walter Reinisch  2     Stefan Schreiber  3     Fraser Cummings  4     Peter Irving  5     Byong Duk Ye  6     Dong-Hyeon Kim  7     Sangwook Yoon  7     Shomron Ben-Horin  8    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
2 Medical University of Vienna, Vienna, Austria
3 University Hospital Schleswig-Holstein, Kiel, Germany
4 University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
5 Guy’s and St Thomas’ Hospital, London, United Kingdom
6 University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
7 Celltrion Healthcare, Incheon, Korea, Republic of
8 Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing